Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trials
André Scheen
Topics & Concepts
MetforminMedicineType 2 diabetesInternal medicineRandomized controlled trialDipeptidyl peptidase-4Diabetes mellitusType 2 Diabetes MellitusSaxagliptinClinical endpointPharmacologyGastroenterologyUrologyEndocrinologySitagliptinDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and Lipoproteins